Go Capital

GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.

Mohamed Abdesslam

Investment Director

Herve Bachelot

Investment Director

AB

Alexandre Boulay

Investment Associate

CB

Clémentine Breysse

Investment Associate

ED

Emmanuelle Deponge

Venture Partner

Bertrand Distinguin

President

Jérôme Féraud

Investment Director

TG

Tristan Garde

Investment Associate

Jérôme Gueret

CEO

Bruno Guicheux

Investment Director

FL

Frédéric Le Guillou

Investment Director

JM

Jean Marc Herbert

Venture Partner

Aude Kermarrec

Administrative and Financial Director

DL

David Leray

Investment Director

Alexis Menard

Investment Director

Leila Nicolas

Investment Director

MQ

Mathieu Quéguiner

Investment Associate

Past deals in France

I-Sep

Seed Round in 2015
i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Carlipa Systems SA

Series C in 2007
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.

VitamFero

Series C in 2015
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

EffiNov Nutrition S.A.S.

Seed Round in 2012
EffiNov Nutrition S.A.S. manufactures vitamin supplements. The company also develops and markets diet programs based on software nutritional analysis. It offers food and nutrition plans for deterioration of general state, digestive disorders, emotional stress, sleep disorders, joint pains, weight loss, and pregnancy. The company was founded in 2010 and is based in Lorient, France.

Acticor Biotech

Series B in 2019
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Graftys

Series A in 2019
Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.

SWEETCH Energy

Venture Round in 2017
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

Pubstack

Series A in 2022
Pubstack is an internet company that collects, processes, and visualize events per day. It delivers a product that customers love, they tackle and solve complex technical problems at scale, using the cloud and today’s best open source technologies.

Expliseat

Venture Round in 2023
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.

Igyxos S.A.

Series A in 2019
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.

Energiency SAS

Series A in 2017
Energiency is SaaS platform to assess and manage energy performance industrial environment.

Shopopop

Funding Round in 2021
Shopopop is a collaborative delivery platform for Drive races and local commerce.

Malkyrs Studio SAS

Venture Round in 2016
Malkyrs Studio offers the opportunity to play a game of physical cards retaining the improvements acquired during the dematerialization of the game on the Internet while enjoying the virtues of the traditional board game. Thus it was possible for us to imagine a game of cards before any physical but proposing an unprecedented digital interaction enriching the experience of the players.

Neli Technologies

Series B in 2010
NELI Technologies is developing a solution for broadcasting digital terrestrial television throughout the home using powerline communication technology.

Aviwest SAS

Series B in 2020
Aviwest SAS develops and markets digital video equipment and solutions for broadcast and security markets. Its products include digital mobile news gathering wireless camera systems that allow broadcasters, content producers, and TV stations to produce professional live video contents, such as breaking news, live shows, and interviews from remote places; and digital audio and video compression boards. The company also provides training, installation, validation, customer support, and maintenance services. Its products are used in digital television and news gathering, and surveillance markets, as well as in military unmanned vehicles and robots. The company was founded in 2008 and is based in Rennes, France.

Blacknut

Seed Round in 2018
Blacknut is the world's leading pure player cloud gaming service dedicated to the general public, distributed both direct to consumers and B2B through ISPs, device manufacturers, OTT services & Media companies. Blacknut offers the largest catalogue of premium games with 400+ premium titles carefully selected for the whole family, all included in a monthly subscription. The service is now available across Europe, Asia & North America on a wide range of devices, including mobiles, set-top-boxes and Smart TVs. Blacknut was founded in 2016 by Olivier Avaro (CEO) and is headquartered in Rennes, France, with offices in Paris, Seoul and San Francisco.

InFlectis BioScience

Series A in 2016
InFlectis BioScience is leveraging its leading expertise in the cellular defense system against misfolded proteins and drug discovery to identify and develop small molecules which modulate key proteins involved in misfolded protein disorders. Endoplasmic Reticulum (ER) proteostasis is vital for cellular function and cell survival. Many different perturbations can alter the folding capacity of the ER and may cause accumulation of unfolded or misfolded proteins inside the ER, a cellular condition referred to as ER stress. To safeguard proteostasis, the mammalian ER has a complex machinery to maintain the integrity of cells. This adaptive programme is called the unfolded protein response (UPR).

BodyCap

Venture Round in 2013
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Highcon Systems Ltd.

Series F in 2017
Highcon delivers innovation and differentiation that converters, printers, and brand owners all need, transforming “finishing” into a value adding process to positively impact users’ profitability by increasing speed to market, eliminating costly production steps and reducing carbon footprint. The Highcon Euclid is the first fully digital cutting and creasing machine for converting paper, labels, folding carton and microflute. The Euclid incorporates Highcon’s patented ‘DART’ (Digital Adhesive Rule Technology) to produce creases, and high-speed laser optics to for cutting and etching. Contact info +972-8-9101705 web site: www.highcon.net

SABELLA SAS

Venture Round in 2016
Sabella is a marine current turbines developer, supplying reliable turnkey energy solutions worldwide. With a differentiated and economically-optimized range of technologies, protected by appropriated patents, Sabella endeavors to promote a new energetic model tailored for remote grids on islands and isolated shore communities.

Monemprunt.com

Seed Round in 2018
Monemprunt.com offers brokerage services for real estate credit. Monemprunt.com was founded in 2016 and is based in Rennes, France.

Aqualeg

Seed Round in 2013
Aqualeg is a company has invented and produces skin-friendly silicone leg prosthesis liners that allow patients to use water in the water, unlike all existing skincare products.

Milestone Pharmaceuticals

Series D in 2018
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Diafir

Venture Round in 2015
DIAFIR developps, manufactures and markets in situ and fast biological analytical tools based upon unique infra red fiber sensor technology. Major applications are POC medical diagnostic, food analysis and organic chemical reaction monitoring. DIAIFR systems allow to detect some chonic liver disease, infection or tumor within a 5 minutes process.

VitaDX International SA

Venture Round in 2020
VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.

VitaDX International SA

Seed Round in 2017
VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.

QOS Energy

Venture Round in 2014
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

SWEETCH Energy

Venture Round in 2021
SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.

Graftys

Venture Round in 2022
Graftys, an Aix-en-Provence, France-based early stage company focused on advanced bone biologics.

Diafir

Venture Round in 2021
DIAFIR developps, manufactures and markets in situ and fast biological analytical tools based upon unique infra red fiber sensor technology. Major applications are POC medical diagnostic, food analysis and organic chemical reaction monitoring. DIAIFR systems allow to detect some chonic liver disease, infection or tumor within a 5 minutes process.

Digitaleo

Venture Round in 2015
Digitaleo provides digital marketing solutions to merchants and retail chains. It collects and uses the data of their customers to allow outlets to better manage their traffic and act in real time on their turnover. Digitaleo specializes in email marketing, CRM, e-commerce, and more. it was launched in 2004 and is based in Rennes, Bretagne.

Velco SAS

Venture Round in 2020
Velco SAS provides a mobile application that tracks and prevents bike theft. It offers Wink, a handlebar paired with smartphone that tracks the trips and prevents bike theft. The company’s application also guides users through its navigation technology. Velco SAS was founded in 2015 and is based in Nantes, France.

Seadev-FermenSys

Venture Round in 2007
Seadev-FermenSys is the exclusive operator of extremophile marine bacteria collections including IFREMER marine hydrothermophilic strains commercialized under an exclusive Trade License.

Alcuin

Funding Round in 2015
Alcuin SAS develops software solutions for talent and training management. The company provides human capital management solutions for talent assessments/surveys, internal mobility/external portal recruitment, employee/manager portals, performance reviews, plan development/plan implementation training, compensation, career planning, and strategic workforce planning to services, banking and insurance, industry, building and public works, health, transport and energy, media, distribution, ready-to-wear, and public sector clients, as well as joint collective training agencies.

Velco SAS

Venture Round in 2021
Velco SAS provides a mobile application that tracks and prevents bike theft. It offers Wink, a handlebar paired with smartphone that tracks the trips and prevents bike theft. The company’s application also guides users through its navigation technology. Velco SAS was founded in 2015 and is based in Nantes, France.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd., a medical device company, develops a platform for diagnosing blood diseases using computer vision technology. The company offers Parasight, a malaria detection device that identifies, enumerates, and speciates malaria. Its device makes use of a staining solution and microscopy platform that is applied to various blood diseases and tests. The company is based in Tel Aviv, Israel.

Qowisio SAS

Venture Round in 2015
Qowisio SAS operates as an IoT solution provider. The company provides connected devices and technological solutions in order to address and accelerates an IoT solutions. It offers tracking, power monitoring, environment monitoring, security monitoring, pallet tracking, temperature monitoring in buildings, and commercial refrigerator monitoring. Qowisio SAS was founded in 2009 and is based in Angers, France with additional offices in Austin, Texas; and Paris, France.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Ideolys SAS

Venture Round in 2018
Ideolys SAS provides Web-based software solutions for catering businesses. The company offers Easilys, an Internet application for the management of B&I, education, and healthcare catering operations; and Easilys Commandes Convives, a customer’s portal for central kitchen’s remote sites and home deliveries. It also provides training, support, hosting, and project management services. Ideolys SAS was founded in 2010 and is based in La Roche sur Yon, France.

VitamFero

Funding Round in 2014
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

LeddarTech Inc.

Series D in 2022
LeddarTech Inc. develops and markets sensing solutions based on light emitting diode (LED) lighting systems. The company provides LED detection and ranging solutions for object detection and distance measurement applications. Its products are used to improve traffic flow by municipalities and DOTs, as well as for parking assistance, automatic parking, blind-spot detection, lane-change assistance, and pre-crash detection applications in the automotive industry. LeddarTech Inc. was founded in 2007 and is based in Quebec City, Canada.

Neosteo SAS

Seed Round in 2012
Neosteo SAS designs implant technologies and instrument kits for orthopaedic surgery. It offers instruments, implants, sterile kits, and patient information; FlexitSystem plates for knee osteotomy; FlexitSystem solution, an implant technology for HTO procedures; and FlexitSystem kits, which include osteosynthesis plates, instrument kits, locking screws, and surgical guide for lateral closing high tibial osteotomy, femoral osteotomy, and proximal tibial osteosynthesis. The company was founded in 2010 and is based in Nantes, France.

SurfactGreen

Venture Round in 2017
Surfact'Green develops, produces and markets patented ecological surfactants from agro-resources such as algae or sugar beet co-products. A business unit of the same name was created in 2011 at the Rennes National School of Chemistry (ENSCR), based on the Organic and Supramolecular Chemistry team (UMR Sciences Chimiques de Rennes), which has been working on these molecules since then. more than ten years. This business unit, supported by SATT Ouest Valorisation, has carried out works in collaboration with other public and private laboratories as well as several industrial companies interested in these surfactants.

Diafir

Seed Round in 2012
DIAFIR developps, manufactures and markets in situ and fast biological analytical tools based upon unique infra red fiber sensor technology. Major applications are POC medical diagnostic, food analysis and organic chemical reaction monitoring. DIAIFR systems allow to detect some chonic liver disease, infection or tumor within a 5 minutes process.

BodyCap

Venture Round in 2015
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

EasyBroadcast

Seed Round in 2016
EasyBroadcast is a company based at the Ecole Centrale de Nantes, a SAAS software editor that optimizes the bandwidth consumed by streaming audio and video content providers (VOD, SVOD and internet service using video). .

Abyss' Ingredients

Seed Round in 2019
Abyss' Ingredients manufactures marine biotechnological ingredients that provides nutrients for infants, children, and adults. The company’s products are used for joints health, metabolic syndrome, anti-inflammatory, cardiovascular protection, digestive health, immunomodulatory, skin health, and brain health. It serves customers in France and internationally. The company was incorporated in 2004 and is based in Caudan, France with locations in Quimper and Lorient, France.

Nextflow Software

Series A in 2020
Nextflow Software operates as an industry specific independent software vendor. It develops and sells computer – aided engineering software in the field of computations fluid dynamic (CFD). Its solution includes ditching and sloshing to aeronautic industry; fording river crossing, gearbox lubrication, hydroplaning, rain on windshield and sloshing to automotive industry; dam break and flooding solutions to energy & environment industry; drilling solutions to industrial processes; ship resistance, wave impact loads and sloshing to marine & offshore industry. Its product includes studio and solvers. Nextflow Software was founded in 2015 and is based in Nantes, France.

EffiNov Nutrition S.A.S.

Venture Round in 2015
EffiNov Nutrition S.A.S. manufactures vitamin supplements. The company also develops and markets diet programs based on software nutritional analysis. It offers food and nutrition plans for deterioration of general state, digestive disorders, emotional stress, sleep disorders, joint pains, weight loss, and pregnancy. The company was founded in 2010 and is based in Lorient, France.

Biosency

Seed Round in 2018
BIOSENCY SAS designs and manufactures medical devices. The company manufactures PPG sensor system that monitors and prevents solution dedicated to respiratory insufficiency. It measures cardio-respiratory parameters at rest and in outpatient efforts. The device provides telemonitoring, prediction, prevention of respiratory insufficiency, and facilitates clinical management. BIOSENCY SAS was founded in 2017 and is based in Cesson-Sévigné, France.

Robocath

Venture Round in 2017
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions. R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

I-Sep

Venture Round in 2017
i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Horama SAS

Series B in 2017
Horama SAS focuses on the development of gene therapy products to rare ophthalmology pathologies with recombinant adeno-associated viral vectors for orphan blinding diseases. Its gene therapy products target retinal dystrophies and retinopathies. The company was founded in 2014 and is headquartered in Paris, France.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd., a medical device company, develops a platform for diagnosing blood diseases using computer vision technology. The company offers Parasight, a malaria detection device that identifies, enumerates, and speciates malaria. Its device makes use of a staining solution and microscopy platform that is applied to various blood diseases and tests. The company is based in Tel Aviv, Israel.

Robocath

Venture Round in 2019
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical procedures safer, thanks to reliable technologies, while complementing manual interventions. R-One™ is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. It is designed to operate with precision and perform specific movements creating better interventional conditions. Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

Shopopop

Venture Round in 2020
Shopopop is a collaborative delivery platform for Drive races and local commerce.

Dictanova

Venture Round in 2016
Founded in 2011 by Fabien Poulard (PhD in Computer Science, automated language processing), Dictanova has developed a cloud based platform that provides text analytics and sentiment analysis services, for all companies who need to understand their customers. This platform allows marketing and customer experience professionals to explore and analyze thousand of client feedbacks in a few minutes. Customer feedback analysis provides keys to understand clients needs, and identify the subjects of tension in the customer experience as well as the delighting factors.

ComparateurAgricole.com

Series A in 2017
ComparateurAgricole.com aims to valorize farmers' stocks by offering the best prices in cereals (wheat, barley, corn ...) and oilseeds (rapeseed). The activity has extended to the supply of fertilizers following the demand of the farmers customers, always with the objective to guarantee the best quality / price ratio. All prices are transparent and accessible in a few clicks. The headquarters of the company is located on the family farm in GOHORY. We made the choice to stay in Beauce, granary of France, to be close to our farmers. For several months, the offices are located in Chartres, in the city of innovation, an innovative business incubator.

Wexity

Seed Round in 2017
Digital City Management Platform, Wexity re-invents urban management solution across high-growth cities in Africa, India, Middel-East and more... By 2050, more than 70% of humans will live in urban areas. City Executives are at the forefront of associated challenges. They need affordable, easy to use and professional solutions to compete. Wexity has been designed to support all these challenges and assists local staff forward.

Vite Mon Marché

Seed Round in 2018
Vite Mon Marché offers urban / Nantes delivery in less than one hour of fresh and local products directly to the home (fruit, vegetables, meat, fish, dairy, drinks ...). Discovered from producers in the outskirts of Nantes, hundreds of fresh and high quality farm produce (organic or not) are offered every day of the week.

InFlectis BioScience

Seed Round in 2015
InFlectis BioScience is leveraging its leading expertise in the cellular defense system against misfolded proteins and drug discovery to identify and develop small molecules which modulate key proteins involved in misfolded protein disorders. Endoplasmic Reticulum (ER) proteostasis is vital for cellular function and cell survival. Many different perturbations can alter the folding capacity of the ER and may cause accumulation of unfolded or misfolded proteins inside the ER, a cellular condition referred to as ER stress. To safeguard proteostasis, the mammalian ER has a complex machinery to maintain the integrity of cells. This adaptive programme is called the unfolded protein response (UPR).

QOS Energy

Venture Round in 2017
QOS ENERGY operates as a software vendor that specializes in energy management systems. The company develops and commercializes Qantum, a Software-as-a-Service solution for the monitoring and management of renewable energy infrastructures. It serves the specific requirements of professional energy performance managers, including medium and large size photovoltaic, wind, hydraulic, and biogas plants; energy efficiency in buildings and industry; and eco-territories and smartgrid projects of various sizes in Europe. The company was founded in 2010 and is based in La Chapelle sur Erdre, France with an additional office in the United Kingdom. QOS ENERGY operates as a subsidiary of The Astelia Group.

Velco SAS

Venture Round in 2018
Velco SAS provides a mobile application that tracks and prevents bike theft. It offers Wink, a handlebar paired with smartphone that tracks the trips and prevents bike theft. The company’s application also guides users through its navigation technology. Velco SAS was founded in 2015 and is based in Nantes, France.

Shopopop

Venture Round in 2018
Shopopop is a collaborative delivery platform for Drive races and local commerce.

QIVIVO, SAS

Venture Round in 2015
QIVIVO is an energy savings provider. Our mission is to help households to regain control of their energy bills. Heating accounts for 65% of the energy bill and we found that temperature of a home can be optimized 35% of the time without degradation of comfort. We provide, therefore, the temperature of the comforts of home cheaper. Through such a box connected to the heating, Qivivo program automatically adjusts the ideal heating for every home.

Seaver

Seed Round in 2017
Seaver SAS develops connected girth products for monitoring horse health and performance. The girth worn by the horse provides owners and coaches with data on heart and respiratory rate, calories, gait, and jump. The company offers connected devices for the equestrian industry. It also develops a mobile application to monitor and track data collected form the girth. Seaver SAS was founded in 2016 and is based in Caen, France.

Augure

Series D in 2008
Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence in the media and on social networks. The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies. Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.

La société LENTILLES

Seed Round in 2011
The company LENTILLES (LCS) is a laboratory specialized in contactology. The Caen-based company has developed a patented process for producing hybrid contact lenses (using flexible polymers and rigid polymers). Laboratoire LCS is a French contact lens manufacturing laboratory , located in Normandy. LCS services a variety of vision needs and supplies ophthalmologists and opticians with a wide range of tailor made rigid and soft lenses.

Quortex

Seed Round in 2020
Quortex develops artificial intelligence based software solution that will lower the infrastructural and network costs for content delivery over the internet. The company was incorporated in 2018 and is based in Cesson-Sévigné, France.

Turbotech

Venture Round in 2018
TURBOTECH S.A.S develops energy storage system for aircraft. The company offers turboprops and turbo electric generators for light aircraft which combines recuperated turbine with electric machine. The company was founded in 2017 and is headquartered in Toussus-Le-Noble, France.

Energiency SAS

Series A in 2020
Energiency is SaaS platform to assess and manage energy performance industrial environment.

Atlanthera

Venture Round in 2014
Atlanthera is a research and development company specialized in new therapeutic approaches in the treatment of bone tumors.

Carlina Technologies

Equity Crowdfunding in 2012
Carlina Technologies is a biotechnology company based in Angers that specializes in the development of micro and nanomedicines using innovative encapsulation processes of small molecules and therapeutic proteins. Carlina, born of the rapprochement between Professor Jean-Pierre Benoit, director of the unit INSERM 1066 (laboratory of Micro and Nanomedecines Biomimetics), and of Olivier Meyer, doctor in Pharmaceutical Sciences of the University of Paris XI, is laureate 2010 national competition to help start up innovative technologies.

Kemwatt SAS

Private Equity Round in 2016
Kemwatt SAS designs, develops, manufactures, and markets batteries with circulating electrolytes for application in stationary storage of electricity to facilitate the management of the network within the framework of renewable electrical production.

Carlipa Systems SA

Series B in 2005
Carlipa Systems offers automated multimedia communication solutions. The company’s products include Kast Engine©, a software engine for real time diffusion and NMG ® that allows automatic control of video and audio flows. These products are used for marketing of point of sale and television of company. Carlipa Systems was founded in 2002 and is based in Saint Nom la Bretèche, France.

Ergosup

Series A in 2015
Ergosup developes an innovative process for producing high pressure hydrogen on site for refueling hydrogen fuel vehicles.

IRIS-RFID

Venture Round in 2009
IRIS-RFID is a private French company established in Paris in August 2007. Their founding engineers have more than 40 years experience in total in the development and implementation of innovative RFID solutions internationally (Canada, United States, Brazil, France, Asia, Africa, etc.).

Augure

Series C in 2006
Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence in the media and on social networks. The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies. Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.

BodyCap

Series A in 2017
BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Milestone Pharmaceuticals

Series C in 2017
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.